Zobrazeno 1 - 10
of 46
pro vyhledávání: '"Gray D. Shaw"'
Autor:
Eran Brown, Koya Ozawa, Federico Moccetti, Amanda Vinson, James Hodovan, The Anh Nguyen, Lindsay Bader, José A. López, Paul Kievit, Gray D. Shaw, Dominic W. Chung, Warren Osborn, Xiaoyun Fu, Junmei Chen, Jonathan R. Lindner
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 10, Iss 9 (2021)
Background Platelet–endothelial interactions are thought to contribute to early atherogenesis. These interactions are potentiated by oxidative stress. We used in vivo molecular imaging to test the hypothesis that platelet–endothelial interactions
Externí odkaz:
https://doaj.org/article/d3eb1c60c5774fd1bb4798a532628291
Glycoprotein Ibα inhibitor (CCP-224) prevents neutrophil-platelet aggregation in sickle cell disease
Publikováno v:
Blood Advances, Vol 1, Iss 20, Pp 1712-1716 (2017)
Externí odkaz:
https://doaj.org/article/d609e844206c4828a2ff51180adbee4f
Autor:
Federico Moccetti, Xiaoyun Fu, James Hodovan, José A. López, Lindsay Bader, Dominic W. Chung, Koya Ozawa, Gray D. Shaw, Eran Brown, Warren Osborn, Junmei Chen, Paul Kievit, Jonathan R. Lindner, Amanda Vinson
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Platelet–endothelial interactions are thought to contribute to early atherogenesis. These interactions are potentiated by oxidative stress. We used in vivo molecular imaging to test the hypothesis that platelet–endothelial interactions
Autor:
Egemen Tutuncuoglu, Prithu Sundd, Tirthadipa Pradhan-Sundd, Gray D. Shaw, Jesús Tejero, Ravi Vats
Publikováno v:
Exp Hematol
Sickle cell disease (SCD) is a monogenic disorder, estimated to affect over three million people worldwide(1,2). Acute systemic painful vaso-occlusive episode (VOE) is the primary reason for emergency medical care among SCD patients(3). VOE may also
Autor:
Shufa Zheng, Yuanxing Liu, Jerzy W. Kupiec-Weglinski, Cheng Zhang, Ronald W. Busuttil, Haofeng Ji, Xiu-Da Shen, Gray D. Shaw, Yu Zhang, Feng Gao, Shoichi Kageyama
Publikováno v:
American Journal of Transplantation. 17:1462-1475
Liver endothelial cell (LEC) damage is essential in the pathogenesis of ischemia-reperfusion injury (IRI) in transplant recipients. We analyzed the mechanism of LEC resistance against IRI by using a novel recombinant soluble form of P selectin glycop
Glycoprotein Ibα inhibitor (CCP-224) prevents neutrophil-platelet aggregation in sickle cell disease
Key Points CCP-224 attenuates neutrophil-platelet aggregation in SCD patient blood. CCP-224 has the potential to prevent vaso-occlusion in SCD patients.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c64507ceb6949d185be560512c2958f6
https://europepmc.org/articles/PMC5617353/
https://europepmc.org/articles/PMC5617353/
Publikováno v:
Blood. 132:2364-2364
Introduction: Sickle cell disease (SCD) is an autosomal-recessive-genetic disorder, which leads to red blood cell sickling, hemolysis and vaso-occlusion. Acute systemic painful vaso-occlusive crisis (VOC) is the predominant pathophysiology requiring
Autor:
Steve Tam, Qin Wang, Adrian Huang, Desiree H.H. Tsao, Natalia Sushkova, Michael Dennis Lowe, Gray D. Shaw, Patricia W. Bedard, Li Di, Boris Tchernychev, James C. Keith, Neelu Kaila, Robert G. Schaub, Kristin Janz, Valerie Clerin, Alessandro Moretto
Publikováno v:
Journal of Medicinal Chemistry. 53:6003-6017
Previously, we reported the discovery of PSI-697 (1a), a C-2 benzyl substituted quinoline salicylic acid-based P-selectin inhibitor. It is active in a variety of animal models of cardiovascular disease. Compound 1a has also been shown to be well tole
Autor:
Robert G. Schaub, Valerie Clerin, David L. Crandall, Gray D. Shaw, Thomas M. Antrilli, Natalia Sushkova, Laura L. Carter, Christine Resmini, Patricia W. Bedard, Kristin Janz, James K. Hennan, Silvano DeBernardo, James C. Keith, Neelu Kaila, Qin Wang, Boris Tchernychev
Publikováno v:
Journal of Pharmacology and Experimental Therapeutics. 324:497-506
P-selectin plays a significant and well documented role in vascular disease by mediating leukocyte and platelet rolling and adhesion. This study characterizes the in vitro activity, pharmacokinetic properties, and the anti-inflammatory and antithromb
Autor:
Thomas R. Meier, Thomas W. Wakefield, Patricia W. Bedard, Neelu Kaila, Angela E. Hawley, Gray D. Shaw, Daniel D. Myers, Shirley K. Wrobleski, Robert G. Schaub, Peter K. Henke
Publikováno v:
Journal of Vascular Surgery. 44:625-632
BackgroundVein wall injury after thrombosis is multifactorial but seems dependent on thrombus and local thrombotic and inflammatory mechanisms. We hypothesized that inhibition of vein wall injury through reduction of thrombotic and inflammatory event